By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: FDA Asks Manufacturers of Hip Replacements To Study Failure Rates
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Devices > FDA Asks Manufacturers of Hip Replacements To Study Failure Rates
Medical DevicesOrthopaedics

FDA Asks Manufacturers of Hip Replacements To Study Failure Rates

BarbaraDuck
BarbaraDuck
Share
3 Min Read
SHARE

The point of the study is to find out how fast and how many will fail, what is the failure rate.  We have Johnson and Johnson largely at the head of this investigation for their DePuy failure rates and recalls, and of course they no longer make the product.  As you can see below at the bottom there are others named in the request and there could be more requests generated as the FDA may look into the entire area of implants before they are done.  BD 

The point of the study is to find out how fast and how many will fail, what is the failure rate.  We have Johnson and Johnson largely at the head of this investigation for their DePuy failure rates and recalls, and of course they no longer make the product.  As you can see below at the bottom there are others named in the request and there could be more requests generated as the FDA may look into the entire area of implants before they are done.  BD 

In an unusual move, the Food and Drug Administration has ordered all producers of a popular category of artificial hip to undertake studies of the implants, which have been linked to high early failure rates and severe health effects in some patients.

In a telephone interview on Tuesday, Dr. William H. Maisel, the deputy director for science at the F.D.A.’s Center for Devices and Radiological Health, said the order marks the broadest use of the agency’s authority to conduct studies of devices after approval for sale. He also said that the F.D.A. wanted information about the entire category of implants, not any single manufacturer’s device.

“This is the largest group of studies that we have asked for,” for an approved class of devices, said Dr. Maisel.

Along with the DePuy division of Johnson & Johnson, other major producers of hip implants include Zimmer, Stryker, Biomet and Wright Medical.

Studies Ordered for Makers of Artificial Hips – NYTimes.com

 

More Read

Image
mHealth: Prevention is Better Than Cure
Implants From OrthoSensor to Monitor Knees for Load, Stability and Functionality
Q&A Part Two: Technology & Healthcare Efficiency—Not Always the Perfect Match
FDA Approves Roche (Genentech) Skin Cancer Drug–Zelboraf
3 Promising Mobile Diagnosis Apps for Medical Practitioners
   

TAGGED:FDAmedical devicesorthopaedics
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

a person putting a bandage on a woman s head
The Long-Term Health Consequences of Untreated Personal Injuries
Health care
July 17, 2026
medicare mistakes seniors usually make
The Hidden Healthcare Costs Seniors Should Plan For
Global Healthcare Senior Care
July 15, 2026
The Complex Reality of Medication Management During Recovery
The Complex Reality of Medication Management During Recovery
Addiction Recovery
July 15, 2026
exercise benefits
How Exercise Shapes The Teenage Body And Mind
Infographics
July 12, 2026

You Might also Like

Urodynamix Develops Non-invasive Diagnostics For Urologic Conditions

March 28, 2011

The PCMH and Home Care Data: An Interview with Melissa McCormack

December 19, 2013
ultrasound
Medical DevicesTechnology

RSNA 2013: Putting the “Ultra” into Ultrasound

December 6, 2013

FDA Approves Roche/Genentech Drug Erivedge to Treat Advanced Skin Cancer Not Treatable with Surgery

February 1, 2012
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?